Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
At the end of 2022, Sosei Heptares had announced that its long-term collaboration with Pfizer had advanced the first candidate drug, Lotiglipron (PF-07081532), to Phase 2 clinical trials
Adrian TE, Ferri GL, Bacarese-Hamilton AJ, Fuessl HS, Polak JM, Bloom SR
Brazil nuts are one of the best sources
This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access 189,00 per year only 15,75 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
L.HenkelR.et al (2020)
The Lancet , 368(9548), 1696-1705
